Site Search
Google Search
search button
Breaking News: Trump Says Michael Cohen Wonít Turn Against Him     - | -     The Million Dollar Question, Will The President Fire Mueller     - | -     Family Of Myanmar Police Chief Evicted From Police Housing     - | -     Nicaragua Protests Over Social Security System Leaves At Least 10 Dead     - | -     Former Smallville Star Allison Mack Charged With Connection To Sex Trafficking Cult     - | -     GOP Congressman Invokes 'The Deep State'
Pfizer Ends Research for New Alzheimer's, Parkinson's Drugs
Get Business & Technology Alerts

viewsViews 566
7 Jan 2018 07:37 PM EST

NEW YORK (Reuters) - Pfizer Inc (PFE.N) is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company announced on Saturday. The company said it expects to eliminate 300 positions from the neuroscience discovery and early development programs in Andover and Cambridge, Massachusetts, and Groton, Connecticut, as it redistributes the money spent on research, according to the emailed statement. Pfizer is not making any changes to research and development funding for tanezumab, which is marketed as a treatment for joint pain from osteoarthritis, fibromyalgia treatment Lyrica, or its rare disease program.

Post Your Comment
Excellent Very Good Good Fair Poor



Recently Posted Comments
FREE
AllMediaNY AllMediaNY AllMedaiNY